Cameroon’s community leaders drive demand for COVID-19 vaccines

Yaoundé – Local leaders, working with over 2300 community mobilizers and 1450 vaccination teams, were crucial to the success of a rapid COVID-19 vaccination drive that saw 52 000 people vaccinated across Cameroon in just five days in July.

Community leader Jean Calvin Nama-Ntse works to build trust in COVID-19 vaccines in the Nkomassia and Nkolbisson communities in the capital Yaoundé. A life-long community member, he is a traditional Chief, Chairman of the Nkolbisson Health District and Chairman of the Management Committee at Nkolbisson’s Integrated Health Centre.

Tell us about the communities you work with?

Here in northern Yaoundé we have both rural and urban areas. We have more than 80 000 people that come from across Cameroon and other African countries like Mali, the Republic of the Congo, Burundi and Central African Republic. With a mix of different religions, we respect the right to worship freely. We’re not a rich community and most people live off small businesses or informal trading.

What are the biggest challenges in fighting COVID-19 and demand for vaccines?

Our population is quite young and although we are generally well informed, not everyone is aware of all the risks from COVID-19, so not everyone sticks to the prevention measures or are keen to get vaccinated.

Despite the flood of information on COVID-19, there is still fear, doubt and scepticism around vaccination. Rumours and misinformation spreading on social media and dreamed up by certain people sow doubt and reluctance to get vaccinated, which leaves people at greater risk.

What are the key lessons from your work?

In my experience, people who have had the disease or seen others suffer with it are far more aware of the risks and are much keener to get vaccinated. If we use more of these people as educators I’m sure they will raise the uptake of vaccines.

Also, when leaders get vaccinated in public other people follow, especially big media personalities, artists and religious leaders. As a community leader I made a point of getting vaccinated in public.

Putting vaccination points in public spaces like markets, at crossroads or near churches also builds confidence in the community and leads to more people coming for vaccination.

Tell us about the support you received from WHO and partners?

I joined workshops on how to mobilize communities and to advocate and access more resources for immunization campaigns. These were run by the Ministry of Public Health, with

the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF) and the German Agency for International Cooperation (GIZ).

I also joined City Council meetings led by District Health Officers. These help us raise demand for COVID-19 vaccines in our communities. About 300 people have been covered by these trainings so far and more are planned for this year.

From these we learned to work more closely in our communities, giving talks on COVID-19 and the need for vaccination in local markets and public spaces. We’ve visited families to speak intimately with them. We’ve given talks to local associations and worked with local media. We’ve also worked with religious leaders and local government authorities on spreading prevention messages as they are trusted and people listen to them.

These days I only use information from trustworthy sources, including from the government, WHO and of course from my own life experience.

Source: World Health Organization. Africa

WHO affirms support for COVID-19 traditional medicine research

Abuja, 17 September, 2022 – The World Health Organization (WHO) has reiterated its continuous support to the the Government of Nigeria in its goal of achieving self-sufficiency in the local production of traditional medicine.

Speaking at the commemoration of the 2021 Traditional Medicine Day held at the Federal Ministry of Health in Abuja on 13 September, Dr Kofi Boateng said WHO remains committed to continue with the support to the Government of Nigeria in its goal of achieving self-sufficiency in the local production of pharmaceuticals (including Vaccines), traditional medicine and other health products.

Emphasising the importance of African Traditional Medicine in the development of the health sector, Dr Boateng, representing the WHO Country Representative, Dr Walter Kazadi Mulombo said that Africa has a long history of traditional medicines and practitioners that play an important role in providing care to populations over centuries.

The theme of 2021 commemoration is “The potential contribution of Traditional Medicine to COVID-19 Response.” Dr Boateng said Nigeria’s listing of 14 herbal medicinal products by NAFDAC against COVID-19 and ongoing clinical trials on them, is in line with the Regional Expert Committee on COVID-19 aim of elevating the standards of clinical trials of traditional medicine for COVID-19.

“The ongoing scientific research projects in the National Institute for Pharmaceutical Research & Development and other higher institutions, highlights the interest of the Government of Nigeria to develop and promote African Traditional Medicines. These are in line with the theme of this year commemoration; The potential contribution of Traditional Medicine to COVID-19 Response.

WHO Nigeria has taken it up to support the ministry and in particular the department of Traditional, Complementary and Alternative Medicines, Complimentary in the review of the Traditional Medicines Policy 2007, review of the Nigeria Pharmacopoeia 2008 and the development of a 5-year strategic plan to implement the new policy and the revised pharmacopoeia. It will also continue to provide technical assistance to the TCAM department, National Institute of Pharmaceutical Research and Development (NIPRD) and NAFDAC in improving the quality of medicinal products and ensure the listing of these products in the National Essential Medicines List, he said

Meanwhile, the Minister of State for Health Dr Adeleke Mamora at the media briefing said the Federal government will not relent in its efforts to develop local content as a means to finding a homegrown solution to ailment affecting Nigerians.

Dr Mamora said one of the tasked assigned to the National Institute for Pharmaceutical Research & Development (NIPRD)and National Agency for Food and Drug Administration & Control(NAFDAC) is to scale up their activities towards the search for a local solution to the pandemic.

He further stated that “FMoH has inaugurated an expert committee as a protocol of evaluation of herbal medicinal products as a way of promoting research and a database of traditional medicine practitioners has been developed for ease of collaboration, research and promotion of traditional medicine in Nigeria.”

“The federal government is also working on a traditional medicine policy and a committee to set up a traditional medicine institute which was triggered by the COVID-19 pandemic.”

Source: World Health Organization. Africa

COVID-19: ANGOLA REPORTS 381 NEW CASES, 73 RECOVERIES

Luanda – Angola announced this Friday the record of 381 new cases, 7 deaths and the recovery of 73 patients.

According to the daily bulletin, 271 cases were diagnosed in Luanda, 45 in Benguela, 18 in Huíla, 14 in Cabinda, 11 in Uíge, 8 in Namibe, 6 in Zaire, 3 in Cunene, 2 in Lunda Norte, 1 in Bengo, 1 in Moxico and 1 in Huambo.

With ages ranging from 1 month to 88 years, the list included 222 male and 159 female patients.

The deaths were registered in the provinces of Huíla, with 3, Namibe with 2, Luanda with 1 and Huambo with 1, respectively.

Among those recovered, 28 reside in Huila, 16 in Benguela, 11 in Namibe, 9 in Uige, 5 in Huambo, 3 in Moxico and 1 in Luanda.

In the last 24 hours, the laboratories processed 3,179 samples.

302 patients are hospitalised in treatment centres, 225 citizens are in institutional quarantine and 2,823 contacts of positive cases are under epidemiological surveillance.

Angola has 52,208 cases, of which 1,378 have died, 45,991 have recovered and 4,839 are active. Of those active, 33 critical, 40 severe, 154 moderate, 78 mild and 4,534 asymptomatic.

Source: Angola Press News Agency

Liberia Launches Integrated Biological and Behavioral Surveillance Survey (IBBSS) Report

Monrovia, September 2021 – The report of the second assessment of the prevalence and distribution of HIV, Syphilis and Viral Hepatitis among key and vulnerable populations in Liberia was launched on Friday, September 10, 2021 in Monrovia.

The observational cross-sectional study, conducted in 10 of the 15 counties in Liberia, used mixed methods sampling methodology, targeting female sex workers, men who have sex with men, transgender, injecting drug users, inmates, long distance transport workers, mobile traders, uniformed service personnel, and gold and diamond miners.

Presenting key findings of the survey, Mr. Janjay M. Jones, Deputy Program Manager for Monitoring and Evaluation at the National AIDS Control Program said the primary reason for conducting the IBBSS is to determine the level of knowledge, perceptions, beliefs and attitudes about HIV, Syphilis and Viral Hepatitis, as well as determining key HIV risk factors, especially with regards to the HIV status and morbidity among key and vulnerable populations in Liberia.

The 106-page report revealed increased HIV prevalence in almost all the population groups, compared to the 2013 figures, with 37.9% (19.8% in 2013) HIV prevalence in men who have sex with men (MSM), followed by transgender women with 27.6% (not included in 2013 IBBSS), uniformed service personnel, 17.6% (5.0% in 2013), female sex workers (FSW), 16.7% (9.8% in 2013), people who inject drugs (PWID), 14.4% (3.9% in 2013), transport workers, 9.6% (4.8% in 2013), and inmates, 5.6% (not included in 2013 IBBSS). Only mobile traders and miners showed slight declines in HIV prevalence from 4.5% in 2013 to 3.8%, and from 3.8% in 2013 to 3.0%, respectively.

Mr. Jones disclosed additional findings from the survey, indicating Hepatitis B was much more prevalent than Syphilis and Hepatitis C among the key populations, particularly MSM (34%), transgender women (21.9%), FSW (20.1%), and PWID (19.2%). Among the vulnerable populations, Hepatitis B prevalence was 25.0% among uniformed service personnel, closely followed by transport workers, inmates, and miners at 21% each, and lowest among mobile traders at 13.1%.

Officially launching the report, Mr. Lewis Wright, Commissioner for Program and Policy at the National AIDS Commission (NAC), said the IBBSS has provided evidence of the issues that require stakeholders working together to address at the level of their various organizations.

“Unless we come together to deal with the situation that the report presents, the goal of ending AIDS would be undermined. If we, as a country, are to celebrate the end of AIDS, we must discourage stigma and discrimination, and embrace diversity and tolerance in all sectors of the country. This needs collectiveness.” Mr. Wright said.

He highlighted that eliminating stigma and discrimination against Persons Living with HIV (PLHIV), Key Populations (KPs) and vulnerable groups will need a deliberate commitment in putting these groups of people at the center of testing, treatment, viral load suppression and ensuring access to health care services.

Speaking at the launching ceremony, Dr. Moses Jeuronlon, WHO Technical Lead for Disease Prevention and Control in the Liberia Country Office said the report was a milestone in the national HIV response. Committing WHO continued support to the national HIV response, he said the report provides evidence for advocacy and resource mobilization. Also speaking for the Liberia Coordinating Mechanism for the Global Fund, Dr. Jeuronlon said they will go beyond engaging Key Populations in consensus building on priority HIV interventions to ensuring their greater participation in implementation of specified differentiated interventions, with the guiding principle to leave no one behind.

Atty. Bowoulo Taylor Kelley, Director for Legislative Assistance, Treaty Matters and Laws at the Independent National Commission on Human Rights (INCHR) said, the IBBSS report is important because it would help inform decision makers, partners and stakeholders in advancing the promotion and protection of rights for everyone, void of any form of discrimination.

To mitigate the issues discovered, the report recommends that stakeholders in Liberia should design targeted HIV programs to increase knowledge and skills to reduce high-risk behaviors for transmitting and acquiring HIV infection among key and vulnerable populations and added that the designs of programs and interventions should be user-friendly, allowing for multiple entry points to facilities to access HIV related information, prevention, and treatment services.

In attendance at the launch, and also making remarks at the occasion were key stakeholders including representatives from the Ministry of Justice, USAID, UNFPA, UNICEF, the UN Human Rights agency (OHCHR), Action Aid-Liberia, Plan International, Civil Society Organizations including networks of Key Populations, and the media, among others. All the speakers pledged their institutions support and commitment in working together to implement the recommendations from the study in support of the National HIV Response.

Source: World Health Organization. Africa

Africa faces 470 million COVID-19 vaccine shortfall in 2021

Brazzaville – As the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa by around 150 million this year, the continent faces almost 500 million doses short of the global year-end target of fully vaccinating 40% of its population. This shortfall comes as Africa tops 8 million COVID-19 cases this week.

With the cutback COVAX is now expected to deliver 470 million doses to Africa this year. These will be enough to vaccinate just 17% of the population, far below the 40% target. An additional 470 million doses are needed to reach the end-year target even if all planned shipments via COVAX, a multilateral initiative aimed at guaranteeing global access to lifesaving COVID-19 vaccines, and the African Union are delivered.

“Export bans and vaccine hoarding have a chokehold on vaccine supplies to Africa. As long as rich countries lock COVAX out of the market, Africa will miss its vaccination goals. The huge gap in vaccine equity is not closing anywhere near fast enough. It is time for vaccine manufacturing countries to open the gates and help protect those facing the greatest risk,” said Dr Matshidiso Moeti, World Health Organization (WHO) Regional Director for Africa.

As export bans, challenges in boosting production at COVAX manufacturing sites and delays in filing for regulatory approvals for new vaccines constrain deliveries, COVAX has called for donor countries to share their supply schedules to give more clarity on deliveries.

COVAX has also called for countries with enough vaccines to give up their place in the queue for deliveries.Manufacturers must deliver to COVAX in line with firm commitments, and countries that are well-advanced with vaccinations must expand and accelerate donations, ensuring doses are available in larger, more predictable volumes and with longer shelf lives.

About 95 million more doses are set to arrive in Africa via COVAX throughout September, which will be the largest shipment the continent receives for any month so far. Yet even as deliveries pick up, Africa has been able to fully vaccinate just 50 million people, or 3.6% of its people.

Around 2% of the nearly 6 billion doses given globally have been administered in Africa. The European Union and the United Kingdom have vaccinated over 60% of their people and high-income countries have administered 48 times more doses per person than low-income nations.

“The staggering inequity and severe lag in shipments of vaccines threatens to turn areas in Africa with low vaccination rates into breeding grounds for vaccine-resistant variants. This could end up sending the whole world back to square one,” said Dr Moeti.

WHO is ramping up support to African countries to identify and address gaps in their COVID-19 vaccine rollouts. WHO has assisted 15 African countries in conducting intra-action reviews, which analyse all aspects of their vaccination campaigns and offer recommendations for improvements. The reviews have shown that vaccine supply security and uncertainty around deliveries has been a major impediment for many African countries.

With over 300 staff in place across Africa supporting the COVID-19 response, WHO is deploying experts and producing support plans in specific areas where countries need tailored assistance, including securing staff, financing, strengthening supply chains and logistics and boosting demand for vaccines.

As of 14 September 2021, there were 8.06 million COVID-19 cases recorded in Africa and while the third wave wanes, there were nearly 125 000 new cases in the week ending on 12 September. While this is a 27% drop from the previous week, weekly new cases are still at about the peak of the first wave and 19 countries continue to report high or fast-rising case numbers.

Deaths fell by 19% to 2531 reported in Africa in the week to September 12th. The highly transmissible Delta variant has been found in 31 African countries. The Alpha variant has been detected in 44 countries and the Beta variant in 39.

Dr Moeti spoke during a virtual press conference today facilitated by APO Group. She was joined by Dr Ayoade Olatunbosun-Alakija, Co-Chair of the African Vaccine Delivery Alliance (AVDA), Ms Aurélia Nguyen, Managing Director, Office of the COVAX Facility, Gavi, the Vaccine Alliance.

Also on hand to respond to questions were Dr Richard Mihigo, Coordinator, Immunization and Vaccines Development Programme, WHO Regional Office for Africa, and Dr Thierno Balde, Regional COVID-19 Deputy Incident Manager, WHO Regional Office for Africa, Dr Humphrey Karamagi, Senior Technical Officer, Health Systems Development, WHO Regional Officer for Africa.

Source: World Health Organization. Africa

COVID-19: ANGOLA REGISTERS 292 NEW INFECTIONS AND 182 RECOVERIES

Luanda – The Angolan health authorities announced, this Monday, 292 new infections, 182 recoveries and 6 deaths in the last 24 hours.

According to the secretary of State for Public Health, Franco Mufinda, there are 197 cases diagnosed in Luanda, 22 in Cabinda, 20 in Huambo, 14 in Cuando Cubango, 12 in Namibe, 9 in Benguela, 6 in Huíla, 5 in Bié, 3 in Moxico, 2 in Uíge, 1 in Cuanza Norte and Malanje, respectively.

With ages ranging from 1 to 85 years, the list included 164 male and 128 female patients.

The deaths, according to Franco Mufinda, were registered in Bié, with 3, Luanda with 2 and Benguela with a single one.

Among those recovered, 134 reside in Luanda, 15 in Huambo, 10 in Namibe, 7 in Benguela and Huíla, 5 in Bié and 4 in Moxico.

In the last 24 hours, the labs processed 2,736 samples, with a 10.6% positivity rate.

About 282 patients are hospitalized in the treatment centers, while 199 citizens are in institutional quarantine and 1,881 contacts of positive cases are under epidemiological surveillance.

The country´s overall registers 50,738 cases, of which 1,345 death, 44,834 recoveries and 4,559 active.

Of the current cases there are in 25 critical conditions, 45 severe, 149 moderate, 63 mild and 4,277 asymptomatic.

Source: Angola Press News Agency

COVID-19: ANGOLA REPORTS 104 NEW CASES, 12 DEATHS

Luanda- Angola has registered, in the last 24 hours, 104 new cases, 12 deaths and the recovery of 30 patients.

According to the figures released, 70 cases were diagnosed in Luanda, 17 in Huila, 5 in Namibe, 3 in Benguela, 3 in Uige, 2 in Bié, 2 in Moxico, 1 in Cunene and 1 in Lunda Norte.

The list includes 52 male and 52 female patients whose ages range from 1 to 88 year old.

According to the data, deaths were reported in the provinces of Huila, with 5, Luanda with 4, Bié with 2 and Namibe with 1.

Among the recovered patients, 9 reside in Namibe, 7 in Huila, 6 in Moxico, 5 in Huambo, 2 in Luanda and 1 in Benguela.

The laboratories processed, in the last 24 hours, 1,652 samples.

There are 270 patients in the hospitalisation centres, while the institutional quarantine centres host 195 citizens.

There are 1,881 contacts of positive cases under medical surveillance.

Angola has 50,446 cases, with 1,339 deaths, 44,652 recovered and 4,455 active. Of the active cases, 23 are critical, 43 serious, 145 moderate, 61 light and 4.183 asymptomatic.

Source: Angola Press News Agency

COVID-19: ANGOLA RECEIVES 500,000 DOSES OF SINOPHARM VACCINE

Luanda – Angola received, this Sunday, 500,000 doses of Sinopharm vaccine against Covid-19, as part of the ongoing vaccination process in the country.

According to the Minister of Health, Sílvia Lutucuta, this is a consignment acquired by the government to reinforce the individual and collective protection measures of the citizens.

“We must fully comply with simple measures, such as wearing the mask correctly, washing hands frequently, avoiding gatherings, promoting distancing between people, because we have community circulation of the virus at national level,” warned Silvia Lutucuta.

Silvia Lutucuta announced the arrival, in the next few days, of another 480,000 doses of vaccine from Sinopharm.

She appealed to the population aged 18 or over to go to the vaccination posts closest to their area of residence because the vaccine is free and safe.

According to the Cabinet minister, the government vaccination target is to immunized at least 60 per cent of the eligible population, a total of 15.8 million people.

Since the beginning of the vaccination process in March this year, more than 2 million Angolans have already been vaccinated.

AstraZeneca, Sinopharm, Sputnik and Johnson& Johnson vaccines are being administered in the country.

Source: Angola Press News Agency

COVID-19: ANGOLA REPORTS 399 NEW INFECTIONS, 5 DEATHS AND 46 RECOVERIES

Luanda – The Angolan health authorities announced this Saturday the record of 399 new cases, 5 deaths and the recovery of 46 patients, in the last 24 hours.

According to the daily bulletin, 247 cases were diagnosed in Luanda, 47 in Benguela, 36 in Bié, 18 in Huambo, 6 in Huíla, 5 in Cuando Cubango, 5 in Zaire, 4 in Cabinda, 3 in Malanje, 2 in Moxico and 1 in Lunda Norte.

Aged between 8 months and 88 years old, the list includes 210 male and 189 female patients.

The deaths were registered in the provinces of Cuando Cubango, with 3, Benguela with 1 and Malanje with 1, respectively.

Among those recovered, 16 reside in Huambo, 12 in Benguela, 8 in Cuando Cubango, 5 in Luanda and 5 in Moxico.

Laboratories have processed, in the last 24 hours, 2,353 samples.

There are 268 patients in the hospitalisation centres and 156 citizens in the institutional quarantine centres.

There are 1,819 contacts of positive cases under medical surveillance.

Angola has 50,342 cases, with 1,327 deaths, 44,622 recovered and 4,393 active. Of the active, 20 critical, 41 serious, 145 moderate, 62 light, 4.215 asymptomatic.

Source: Angola Press News Agency

WHO Donates Essential Supplies to Strengthen the Health System Response to COVID-19

The WHO Acting Country Representative, Dr. Zabulon Yoti and the Deputy Chief of Mission of the Embassy of the Federal Republic of Germany Mr. Peter Speyrer, on 7 September 2021 handed over a donation of 462 boxes (924,000 pieces) of facemasks and 11 pieces of GeneX-pert machine modules to the Ministry of Health. The donation of the facemasks was made possible through support provided to the WHO Country Office by the German Government. This support has been channeled through a project which aimed at strengthening emergency preparedness and response and procurement of personal protective and diagnostic equipment.

Speaking during the ceremony, the WHO Acting Representative, Dr. Zabulon Yoti, said that with the COVID-19 resurgence, WHO is partnering with other donors and stakeholders to urgently boost all interventions areas in ensuring the availability of sufficient supplies and diagnostic equipment which are critical requirement. Dr. Yoti said the use of facemask has become extremely important in this time of the COVID-19 pandemic but, can also be used to support the other areas of health. “Expanding the capacity for COVID-19 testing is key to slowing down COVID-19 transmission and reducing sickness and death in the country,” said Dr. Yoti.

The Deputy Health Minister for Planning, Policy Monitoring and Evaluation and Research at the Ministry of Health, Mr. Vaifee Tulay received the donation on behalf of the Honorable Minister of Health. Hon. Tulay said that the donation would help the country in its COVID-19 prevention efforts and testing for COVID-19 as well as other diseases like HIV. He commended the German Government and WHO for the collaboration in supporting the country’s response. The Government of Germany is one of the main partners supporting health infrastructure development as well as providing support for critical commodities.

WHO continues to support the Government of Liberia in the response to COVID-19, including through strengthening laboratory capacity. WHO is also working with the Government for the continuation of essential and routine health services throughout the country.

Source: World Health Organization. Africa